By TCD REPORTS
The United States of America government has approved the first injectable drug to prevent HIV and Aids infection.
People at danger of getting HIV will now have an injectable alternative for pre-exposure prophylaxis (Prep) after the US giant control approved its use in adults and adolescents, the TCD has learnt.
The injectable prescription, cabotegravir, which goes by the brand name Apretude, is the first ever injectable HIV Prep option that at-risk people will take at intervals of two months.
The caveat for its use, as imposed by the Food and Drug Administration, is that the user has to be HIV negative and weigh at least 35 kilogrammes.
Before this approval, other forms of PrEP that were taken by HIV negative at-risk individuals were daily pills and so far, only two types of those— Truvada and Descovy— had been approved for use.
More to follow